ALPINE IMMUNE SCIENCES, INC. Operating Lease, Payments
ALPINE IMMUNE SCIENCES, INC. reported Operating Lease, Payments of $2.06 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2024-03-20
- ALPINE IMMUNE SCIENCES, INC. operating lease, payments for the quarter ending 2019-12-31 was $155.00K.
- ALPINE IMMUNE SCIENCES, INC. operating lease, payments for the quarter ending 2019-09-30 was $230.00K.
- ALPINE IMMUNE SCIENCES, INC. operating lease, payments for the quarter ending 2019-06-30 was $226.00K.
- ALPINE IMMUNE SCIENCES, INC. operating lease, payments for the quarter ending 2019-03-31 was $226.00K.
- ALPINE IMMUNE SCIENCES, INC. operating lease, payments for fiscal 2023 was $2.06M, a 2.64% increase from fiscal 2022.
- ALPINE IMMUNE SCIENCES, INC. operating lease, payments for fiscal 2022 was $2.01M, a 5.10% decline from fiscal 2021.
- ALPINE IMMUNE SCIENCES, INC. operating lease, payments for fiscal 2021 was $2.12M, a 893.90% increase from fiscal 2020.
- ALPINE IMMUNE SCIENCES, INC. operating lease, payments for fiscal 2020 was $213.00K, a 74.55% decline from fiscal 2019.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2023-12-31 | $2.06M 10-K · filed 2024-03-20 | |||
| 2022-12-31 | $2.01M 10-K · filed 2024-03-20 | |||
| 2021-12-31 | $2.12M 10-K · filed 2024-03-20 | |||
| 2020-12-31 | $213.00K 10-K · filed 2023-03-23 | |||
| 2019-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $385.00K derived: sum of 2 quarters · filed 2021-03-18 | $611.00K derived: sum of 3 quarters · filed 2021-03-18 | $837.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | $230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $456.00K derived: sum of 2 quarters · filed 2019-11-14 | $682.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $226.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $452.00K 10-Q · filed 2019-08-13 | ||
| 2019-03-31 | $226.00K 10-Q · filed 2019-05-09 |